Skip to content
Entinostat
Entinostat is a small molecule pharmaceutical. It is currently being investigated in clinical studies. It is known to target histone deacetylase 9, histone deacetylase 1, histone deacetylase 3, and histone deacetylase 2.
Download report
Favorite
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
No data
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
L: Antineoplastic and immunomodulating agents
L01: Antineoplastic agents
L01X: Other antineoplastic agents in atc
L01XH: Histone deacetylase (hdac) inhibitors
L01XH05: Entinostat
HCPCS
No data
Clinical
Clinical Trials
70 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Breast neoplasmsD001943EFO_0003869C50128220
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Non-small-cell lung carcinomaD0022897711
NeoplasmsD009369C80929
Myeloid leukemia acuteD015470C92.0235
Myelodysplastic syndromesD009190D46325
Kidney neoplasmsD007680EFO_0003865C64424
Triple negative breast neoplasmsD064726224
Precursor cell lymphoblastic leukemia-lymphomaD054198C91.0324
Pancreatic neoplasmsD010190EFO_0003860C25324
LymphomaD008223C85.9324
Myelomonocytic leukemia chronicD015477C93.1123
Show 32 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients44
Lung neoplasmsD008175C34.9033
LeukemiaD007938C9522
Invasive hydatidiform moleD002820D39.222
Digestive system neoplasmsD00406722
Lung diseasesD008171EFO_0003818J98.422
Respiratory tract neoplasmsD012142EFO_0003853D1422
Bronchogenic carcinomaD00228322
Thoracic neoplasmsD01389922
Neoplasms by histologic typeD00937022
Show 28 more
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameENTINOSTAT
INNentinostat
Description
Entinostat is a member of the class of benzamides resulting from the formal condensation of the carboxy group of the pyridin-3-ylmethyl carbamate derivative of p-(aminomethyl)benzoic acid with one of the amino groups of benzene-1,2-diamine. It is an inhibitor of histone deacetylase isoform 1 (HDAC1) and isoform 3 (HDAC3). It has a role as an EC 3.5.1.98 (histone deacetylase) inhibitor, an antineoplastic agent and an apoptosis inducer. It is a member of pyridines, a carbamate ester, a substituted aniline, a primary amino compound and a member of benzamides. It is functionally related to a 1,2-phenylenediamine.
Classification
Small molecule
Drug classenzyme inhibitors: histone deacetylase inhibitors
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
Nc1ccccc1NC(=O)c1ccc(CNC(=O)OCc2cccnc2)cc1
Identifiers
PDB
CAS-ID209783-80-2
RxCUI
ChEMBL IDCHEMBL27759
ChEBI ID
PubChem CID4261
DrugBankDB11841
UNII ID1ZNY4FKK9H (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
HDAC9
HDAC9
HDAC1
HDAC1
HDAC3
HDAC3
HDAC2
HDAC2
Organism
Homo sapiens
Gene name
HDAC9
Gene synonyms
HDAC7, HDAC7B, HDRP, KIAA0744, MITR
NCBI Gene ID
Protein name
histone deacetylase 9
Protein synonyms
HD7, HD7b, histone deacetylase 4/5-related protein, Histone deacetylase 7B, Histone deacetylase-related protein, MEF-2 interacting transcription repressor (MITR) protein, MEF2-interacting transcription repressor MITR
Uniprot ID
Mouse ortholog
Hdac9 (79221)
histone deacetylase 9 (Q99N13)
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 3,283 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
116 adverse events reported
View more details